What is the catalog number for Anti-Hu CD7 PerCP?

The catalog number for Anti-Hu CD7 PerCP is PC-206-T100.

What sizes are available for Anti-Hu CD7 PerCP?

Anti-Hu CD7 PerCP is available in the following size(s): 100 Tests.

Is Anti-Hu CD7 PerCP in stock?

Anti-Hu CD7 PerCP is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Anti-Hu CD7 PerCP?

Anti-Hu CD7 PerCP is manufactured by AFG-XBO.

What is the estimated delivery time for Anti-Hu CD7 PerCP?

Estimated delivery time for Anti-Hu CD7 PerCP is approximately 10 business day(s), depending on your location.

Anti-Hu CD7 PerCP

CD7, also known as gp40, is a member of the immunoglobulin superfamily found on T cells, NK cells, thymocytes, hematopoietic progenitors, and monocytes (weakly) . CD7 is also expressed on acute lymphocytic leukemia (ALL) . CD7 crosslinking induces a calcium flux in T lymphocytes, presumably as a result of cytoplasmic domain association with PI3-kinase. CD7 co-stimulation can induce cytokine secretion and modulate cellular adhesion. A ligand of CD7, epithelial cell secreted protein K12, is produced in thymus to regulate thymocyte signaling and cytokine release. In lung microvascular endothelial cells CD7 serves as an IgM Fc receptor. Expression of CD7 is an important marker used in leukemia diagnostics.

Product Specifications

Certification

RUO

Reactivity

Human

Immunogen

Human acute myelogenous leukaemia cell line KG-1.

Target Antigen

CD7

Clone

MEM-186

Applications

FC (QC tested)

Format

PerCP

Buffer

Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

References & Citations

*Weijler L, Kowarsch F, Wödlinger M, Reiter M, Maurer-Granofszky M, Schumich A, Dworzak MN: UMAP based anomaly detection for minimal residual disease quantification within acute myeloid leukemia. Cancers (Basel) 2022 Feb 11;14 (4) :898., URL: https://pubmed.ncbi.nlm.nih.gov/35205645/

Other References

*Nishimura M, Takanashi M, Okazaki H, Satake M, Nakajima K: Role of CD7 expressed in lung microvascular endothelial cells as Fc receptor for immunoglobulin M. Endothelium. 2006 Jul-Aug;13 (4) :287-92., URL: https://pubmed.ncbi.nlm.nih.gov/16990185/, *Chang H, Yeung J, Brandwein J, Yi QL: CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotype. Leuk Res. 2007 Feb;31 (2) :157-62. Epub 2006 Jul 11., URL: https://pubmed.ncbi.nlm.nih.gov/16837044/, *Lam GK, Liao HX, Xue Y, Alam SM, Scearce RM, Kaufman RE, Sempowski GD, Haynes BF. Expression of the CD7 ligand K-12 in human thymic epithelial cells: regulation by IFN-gamma. J Clin Immunol. 2005 Jan;25 (1) :41-9., URL: https://pubmed.ncbi.nlm.nih.gov/15742156/, *Alaibac M, Pigozzi B, Belloni-Fortina A, Michelotto A, Saponeri A, Peserico A. CD7 expression in reactive and malignant human skin T-lymphocytes. Anticancer Res. 2003 May-Jun;23 (3B) :2707-10., URL: https://pubmed.ncbi.nlm.nih.gov/12894562/

Storage Conditions

Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.

Specificity

The antibody MEM-186 reacts with an extracellular epitope of CD7, a 40 kD type I transmembrane glycoprotein expressed on peripheral blood T lymphocytes, NK-cells, hematopoietic progenitors, monocytes (weakly) and also on acute lymphocytic leukemia.